# A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Darat

Source: https://onco.cc/trials/nct04973605/  
OnCo record `nct04973605` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Sonrotoclax, Dexamethasone, Carfilzomib in multiple myeloma, run by BeOne Medicines, now recruiting.

## Summary

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma is a phase 1/2 interventional study registered as NCT04973605 by BeOne Medicines, with 246 participants planned, started 2021-09-16 and due to reach its primary completion in 2026-11. Interventions recorded: Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab, Pomalidomide. Conditions listed: Relapsed/Refractory Multiple Myeloma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT04973605
- Phase: 1/2
- Setting: A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417as Monotherapy, in Combination With Dexamethasone, Dexamethasone/Carfilzomib, Dexamethasone/Daratumumab, and Dexamethasone/Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)
- Sponsor: BeOne Medicines
- Enrolled: 246

## Sources

- ClinicalTrials.gov NCT04973605: https://clinicaltrials.gov/study/NCT04973605

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- drugs: [Carfilzomib](https://onco.cc/drugs/carfilzomib/), [Daratumumab](https://onco.cc/drugs/daratumumab/), [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Pomalidomide](https://onco.cc/drugs/pomalidomide/), [Sonrotoclax](https://onco.cc/drugs/sonrotoclax/)
- companies: [BeOne Medicines (formerly BeiGene)](https://onco.cc/companies/beone/)

---
JSON: https://onco.cc/api/v1/entities/nct04973605.json